Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity

Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity [RAW_REF_TEXT] Tao Qin1,2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Bai Li1,2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Xiaoyue Feng1,2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Shujun Fan1,2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Lei Liu3, [/RAW_REF_TEXT] [RAW_REF_TEXT] Dandan Liu1,2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Jun Mao1,2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Ying Lu4, [/RAW_REF_TEXT] [RAW_REF_TEXT] Jinfeng Yang5, [/RAW_REF_TEXT] [RAW_REF_TEXT] Xiaotang Yu1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Qingqing Zhang1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Jun Zhang6, [/RAW_REF_TEXT] [RAW_REF_TEXT] Bo Song1,2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Man Li 7 & [/RAW_REF_TEXT] [RAW_REF_TEXT] Lianhong Li 1,2 [/RAW_REF_TEXT] Journal of Experimental & Clinical Cancer Research volume 40, Article number: 354 (2021) Cite this article [RAW_REF_TEXT] 114 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] 1 Altmetric [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] The Original Article was published on 27 November 2018 Correction to: J Exp Clin Cancer Res 37, 287 (2018) https://doi.org/10.1186/s13046-018-0934-9 Following publication of the original article [1], the authors identified minor errors in Fig. 6; specifically, in Fig. 6D, the incorrect transwell analysis image was used for the siUSP37#2 group without purmorphamine (bottom left image). GAPDH was examined as a loading control. **P < 0.01,***P < 0.001. b Immunofluorescence staining images of MCF-7 cells showed the expression of USP37 and Hedgehog pathway constituents. c Protein levels of USP37, Smo, Gli-1, ALDH1, OCT4, E-cadherin, N-cadherin, Snail1 as detected by western blotting after the NC siRNA group or the USP37 siRNA#2 group was treated with 0.5 μM purmorphamine for 48 h. GAPDH was examined as a loading control. **P < 0.01,***P < 0.001. d Cell invasion capacity of the NC siRNA group or the USP37 siRNA#2 group treated with 0.5 μM purmorphamine (Scale bar: 200 μm). e Spheroid formation capacity of MCF-7-ShScramble or MCF-7-shUSP37#2 cells treated with 0.5 μM purmorphamine (original magnification, 4×). f Immunofluorescence staining of E-cadherin and N-cadherin after the NC siRNA group or the USP37 siRNA#2 group treated with 0.5 μM purmorphamine for 48 h. (Scale bar: 50 μm). *P < 0.05, **P < 0.01 Full size image The corrected figure is provided here. Abnormally elevated USP37 expression in breast cancer stem cells regulates st